SMTL ID : 4r3c.1

Crystal structure of p38 alpha MAP kinase in complex with a novel isoform selective drug candidate

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.06 Å

Oligo State

monomer

Ligands

1 x GG5: 4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE(Non-covalent)

GG5.1: 13 residues within 4Å: Chain A: P.214, E.215, L.218, W.220, L.259, P.265, L.269, K.272, I.273, I.282, L.314, D.315, S.316 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:P.214, A:L.218, A:L.218, A:W.220, A:P.265, A:L.269, A:L.269, A:I.273, A:L.314 Hydrogen bonds: A:S.316 Water bridges: A:D.317 pi-Stacking: A:W.220

2 x 3GF: 6-(4-methylpiperazin-1-yl)-3-(naphthalen-2-yl)-4-(pyridin-4-yl)pyridazine(Non-covalent)

3GF.2: 15 residues within 4Å: Chain A: V.61, A.74, K.76, L.98, L.109, L.127, V.128, T.129, H.130, L.131, M.132, D.135, S.177, L.190, D.191 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:V.61, A:A.74, A:K.76, A:L.98, A:L.109, A:L.127, A:T.129, A:L.190 Hydrogen bonds: A:K.76, A:M.132 Salt bridges: A:D.135 3GF.3: 5 residues within 4Å: Chain A: T.30, E.45, R.46, Q.48, T.67 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:E.45, A:Q.48, A:T.67 Hydrogen bonds: A:E.45

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.4: 3 residues within 4Å: Chain A: G.54, S.55, G.56 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Roy, S.M. et al., Targeting human central nervous system protein kinases: An isoform selective p38 alpha MAPK inhibitor that attenuates disease progression in Alzheimer's disease mouse models. ACS Chem Neurosci (2015)

Release Date

2015-02-25

Peptides

Mitogen-activated protein kinase 14: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase 14

Related Entries With Identical Sequence